Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ELVN
#1719
Enliven Therapeutics, Inc. Common Stock
29.690
0
+2.63%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+2.63%
Monthly Change
+13.58%
6 month change
+43.71%
Cambio anual
+43.71%
Cierres anteriores
28.930
0
Open
29.700
0
Bid
Ask
Low
29.690
0
High
29.700
0
Volumen
140
Markets
Acciones
Atención Sanitaria
ELVN
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
17.58 M
26.29 M
26.23 M
41.35 M
49 M
—
Valuation ratios
Enterprise value
—
—
—
515.94 M
978.48 M
4.02 B
Price to earnings ratio
—
—
—
-7.41
-11.9
-43.31
Price to sales ratio
—
—
—
—
96.28 K
—
Price to cash flow ratio
—
—
—
8.64
14.47
56.17
Price to book ratio
—
—
—
2.15
3.42
5.64
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.46
0.55
0.02
0.26
0.27
0.26
Return on equity %
0.49
0.6
0.02
0.29
0.29
0.27
Return on invested capital %
51.61 K
33.32 K
156.69
2 319.69
1 935.13
2 536.97
Gross margin %
—
—
100
—
100
—
Operating margin %
—
—
4 562.5
—
950.49 K
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
9 300
—
809.31 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
14.47
12.86
48.98
10.28
19.99
106.58
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
0
—
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
1.35
1.72
1.55
1.39
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
3.34
7.12
6.66
29.55
Net current asset value per share
—
—
3.4
7.49
6.76
29.92
Tangible book value per share
—
—
3.42
6.92
6.58
29.38
Working capital per share
—
—
3.33
6.76
6.42
28.78
Book value per share
—
—
3.42
6.92
6.58
29.38
Noticias
Heyman, director de Enliven Therapeutics, vende acciones por 32.000 dólares
Heyman, director de Enliven Therapeutics, vende acciones por $32k
Heyman, Enliven Therapeutics director, sells $32k in stock
Lyssikatos, Director Científico de Enliven Therapeutics, vende acciones por 145.000 dólares
Lyssikatos, CSO de Enliven Therapeutics, vende acciones por $145k
Lyssikatos, Enliven Therapeutics CSO, sells $145k in shares
Lyssikatos, director científico de Enliven Therapeutics, vende 535.000 dólares en acciones de ELVN
Lyssikatos, Enliven Therapeutics CSO, sells $535k in ELVN stock
Director de Enliven Therapeutics, Heyman, vende acciones por 32.901 dólares
Director de Enliven Therapeutics, Heyman, vende acciones por $32,901
Enliven Therapeutics director Heyman sells $32,901 in stock
Anish Patel, director de operaciones de Enliven Therapeutics, vende 1,35 millones de dólares en ELVN